Published in Arch Intern Med on November 27, 2006
Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev (2011) 5.30
Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. JAMA Intern Med (2015) 5.29
Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database. BMJ (2010) 5.19
Treatment of obesity in primary care practice in the United States: a systematic review. J Gen Intern Med (2009) 2.89
Effects of benefits and harms on older persons' willingness to take medication for primary cardiovascular prevention. Arch Intern Med (2011) 1.97
Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des Devel Ther (2011) 1.68
Predictors of nonadherence to statins: a systematic review and meta-analysis. Ann Pharmacother (2010) 1.66
Perspective on the 2013 American Heart Association/American College of Cardiology guideline for the use of statins in primary prevention of low-risk individuals. Circ Res (2014) 1.37
Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis. BMC Med (2014) 1.31
Alterations in cholesterol absorption/synthesis markers characterize Framingham offspring study participants with CHD. J Lipid Res (2009) 1.29
Coronary artery calcium in relation to initiation and continuation of cardiovascular preventive medications: The Multi-Ethnic Study of Atherosclerosis (MESA). Circ Cardiovasc Qual Outcomes (2010) 1.27
Patient and general practitioner attitudes to taking medication to prevent cardiovascular disease after receiving detailed information on risks and benefits of treatment: a qualitative study. BMC Fam Pract (2011) 1.16
Patients' perspectives on nonadherence to statin therapy: a focus-group study. Perm J (2010) 1.12
Statins in the primary prevention of cardiovascular disease. Nat Rev Cardiol (2013) 1.12
Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes. Int J Vasc Med (2012) 1.12
Impact of better adherence to statin agents in the primary prevention of coronary artery disease. Eur J Clin Pharmacol (2009) 1.11
Is statin use associated with prostate cancer aggressiveness? BJU Int (2009) 1.09
Update on statin-mediated anti-inflammatory activities in atherosclerosis. Semin Immunopathol (2009) 1.04
Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trials. Heart (2007) 1.04
The pleiotropic effects of simvastatin on retinal microvascular endothelium has important implications for ischaemic retinopathies. PLoS One (2008) 1.01
Lipid-lowering therapy: who can benefit? Vasc Health Risk Manag (2011) 1.01
Statin Use, Diabetes Incidence and Overall Mortality in Normoglycemic and Impaired Fasting Glucose Patients. J Gen Intern Med (2016) 0.97
Are investments in disease prevention complements? The case of statins and health behaviors. J Health Econ (2014) 0.93
Intensive lowering of low-density lipoprotein cholesterol levels for primary prevention of coronary artery disease. Mayo Clin Proc (2009) 0.88
Does use of pooled cohort risk score overestimate the use of statin?: a retrospective cohort study in a primary care setting. BMC Fam Pract (2014) 0.87
Statins as potential antimalarial drugs: low relative potency and lack of synergy with conventional antimalarial drugs. Antimicrob Agents Chemother (2009) 0.85
Evidence-based statin prescription for cardiovascular protection in renal impairment. Clin Exp Nephrol (2011) 0.84
Statins enhance clonal growth of late outgrowth endothelial progenitors and increase myocardial capillary density in the chronically ischemic heart. PLoS One (2011) 0.83
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: An Overview of Systematic Reviews. JAMA Cardiol (2016) 0.82
How confidence intervals become confusion intervals. BMC Med Res Methodol (2013) 0.81
Targeting cardiovascular risk in rheumatoid arthritis: a dual role for statins. Nat Rev Rheumatol (2010) 0.81
Effect of simvastatin and atorvastatin on serum vitamin d and bone mineral density in hypercholesterolemic patients: a cross-sectional study. J Osteoporos (2014) 0.81
Effect of cardiovascular prevention strategies on incident coronary disease hospitalisation rates in Spain; an ecological time series analysis. BMJ Open (2014) 0.80
Practice variation in a longitudinal perspective: a multilevel analysis of the prescription of simvastatin in general practices between 2003 and 2009. Eur J Clin Pharmacol (2011) 0.80
Relationship between universal health outcome priorities and willingness to take medication for primary prevention of myocardial infarction. J Am Geriatr Soc (2014) 0.79
Lipoprotein-associated oxidative stress: a new twist to the postprandial hypothesis. Int J Mol Sci (2014) 0.78
Primary prevention of CVD: treating dyslipidaemia. BMJ Clin Evid (2010) 0.78
Using imputed pre-treatment cholesterol in a propensity score model to reduce confounding by indication: results from the multi-ethnic study of atherosclerosis. BMC Med Res Methodol (2013) 0.78
Cost-effectiveness and cost-utility analysis of OTC use of simvastatin 10 mg for the primary prevention of myocardial infarction in Iranian men. Daru (2015) 0.77
Intensified low-density lipoprotein-cholesterol target of statin therapy and cancer risk: a meta-analysis. Lipids Health Dis (2015) 0.77
The role of statins in primary prevention of cardiovascular disease. Arch Intern Med (2007) 0.76
Primary prevention of CVD: treating dyslipidaemia. BMJ Clin Evid (2008) 0.76
The preexposure prophylaxis revolution: from clinical trials to routine practice: implementation view from the USA. Curr Opin HIV AIDS (2016) 0.75
The efficacy and cost-effectiveness of statins in low-risk patients. CMAJ (2011) 0.75
Influence of medication risks and benefits on treatment preferences in older patients with multimorbidity. Patient Prefer Adherence (2017) 0.75
Pantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: a triple-blinded placebo and diet-controlled investigation. Vasc Health Risk Manag (2014) 0.75
Ezetimibe and simvastatin for the prevention of cardiovascular events in predialysis chronic kidney disease patients: a review. Int J Nephrol Renovasc Dis (2012) 0.75
Cardiovascular risk factor modification among high-risk patients: Do pharmacists play a role? Can Pharm J (Ott) (2013) 0.75
Should Statins Be Started In All Type 2 Diabetics Irrespective of LDL-Cholesterol Level? Malays Fam Physician (2007) 0.75
In the absence of heart disease, smaller benefits from statins. J Fam Pract (2007) 0.75
Simultaneous administration of fluoxetine and simvastatin ameliorates lipid profile, improves brain level of neurotransmitters, and increases bioavailability of simvastatin. J Exp Pharmacol (2017) 0.75
Clinical Characteristics and Unmet Need Among Patients with Atherosclerotic Cardiovascular Disease Stratified by Statin Use. Am Health Drug Benefits (2016) 0.75
Cost-effectiveness of diagnostic evaluation strategies for individuals with stable chest pain syndrome and suspected coronary artery disease. Clin Imaging (2017) 0.75
Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 update. Wien Klin Wochenschr (2016) 0.75
Vulnerabilities to Health Disparities and Statin Use in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. J Am Heart Assoc (2017) 0.75
Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med (2005) 8.44
High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology (2009) 7.40
Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA (2008) 6.63
The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med (2010) 3.78
Burden of changes in pill appearance for patients receiving generic cardiovascular medications after myocardial infarction: cohort and nested case-control studies. Ann Intern Med (2014) 3.62
Altitude and all-cause mortality in incident dialysis patients. JAMA (2009) 3.62
Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med (2010) 3.57
Effect of smoking on comparative efficacy of antiplatelet agents: systematic review, meta-analysis, and indirect comparison. BMJ (2013) 3.43
Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol (2005) 3.33
Online social networking by patients with diabetes: a qualitative evaluation of communication with Facebook. J Gen Intern Med (2010) 3.31
Variations in pill appearance of antiepileptic drugs and the risk of nonadherence. JAMA Intern Med (2013) 3.13
Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome. Circulation (2009) 3.09
Compliance with osteoporosis medications. Arch Intern Med (2005) 2.91
The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients. Am J Med (2013) 2.77
The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol (2011) 2.61
Patients' perceptions of generic medications. Health Aff (Millwood) (2009) 2.54
Statin adherence and risk of accidents: a cautionary tale. Circulation (2009) 2.47
Evaluating uses of data mining techniques in propensity score estimation: a simulation study. Pharmacoepidemiol Drug Saf (2008) 2.42
Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture. Ann Intern Med (2008) 2.40
Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med Care (2007) 2.31
Evidence of sample use among new users of statins: implications for pharmacoepidemiology. Med Care (2014) 2.22
Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011. J Clin Endocrinol Metab (2014) 2.18
Variability in pharmacy interpretations of physician prescriptions. Med Care (2009) 2.18
Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications. Am J Med (2012) 2.13
Assessing health state utilities in elderly patients at cardiovascular risk. Med Decis Making (2006) 2.12
Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011. Obstet Gynecol (2014) 2.11
Trouble getting started: predictors of primary medication nonadherence. Am J Med (2011) 2.09
Does this patient with a pericardial effusion have cardiac tamponade? JAMA (2007) 2.04
Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial. Arch Intern Med (2012) 1.94
Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis (2011) 1.92
Measuring concurrent adherence to multiple related medications. Am J Manag Care (2009) 1.88
Preoperative statin use and postoperative acute kidney injury. Am J Med (2012) 1.87
Unregulated private markets for health care in Canada? Rules of professional misconduct, physician kickbacks and physician self-referral. CMAJ (2004) 1.85
Modes of delivery for interventions to improve cardiovascular medication adherence. Am J Manag Care (2010) 1.83
The variability and quality of medication container labels. Arch Intern Med (2007) 1.83
Value-based insurance design: quality improvement but no cost savings. Health Aff (Millwood) (2013) 1.81
Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004. J Rheumatol (2007) 1.80
Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. J Am Coll Cardiol (2008) 1.79
Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events. Am J Cardiol (2008) 1.78
Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study. Ann Intern Med (2014) 1.78
Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives. Hypertension (2005) 1.77
Healthy user and related biases in observational studies of preventive interventions: a primer for physicians. J Gen Intern Med (2011) 1.74
The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration. Pharmacoepidemiol Drug Saf (2011) 1.74
Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationships. J Clin Epidemiol (2009) 1.73
Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples. Am J Epidemiol (2011) 1.72
Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Arthritis Rheum (2011) 1.68
Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol (2011) 1.67
Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis. Drugs (2010) 1.67
Doubly robust estimation of causal effects. Am J Epidemiol (2011) 1.66
Do blood tests cause anemia in hospitalized patients? The effect of diagnostic phlebotomy on hemoglobin and hematocrit levels. J Gen Intern Med (2005) 1.66
An information criterion for marginal structural models. Stat Med (2012) 1.65
Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment. Arch Intern Med (2012) 1.64
The use of generic drugs in prevention of chronic disease is far more cost-effective than thought, and may save money. Health Aff (Millwood) (2011) 1.64
Does this patient with palpitations have a cardiac arrhythmia? JAMA (2009) 1.63
Cost-effectiveness of novel regimens for the treatment of hepatitis C virus. Ann Intern Med (2015) 1.61
Kidney function and use of recommended medications after myocardial infarction in elderly patients. Clin J Am Soc Nephrol (2006) 1.60
Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis. Arthritis Rheum (2006) 1.60
Patient, physician, and payment predictors of statin adherence. Med Care (2010) 1.59
A randomized, controlled trial of in-home drinking water intervention to reduce gastrointestinal illness. Am J Epidemiol (2005) 1.59
Instrumental variable analysis for estimation of treatment effects with dichotomous outcomes. Am J Epidemiol (2008) 1.59
At Pitney Bowes, value-based insurance design cut copayments and increased drug adherence. Health Aff (Millwood) (2010) 1.59
Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010). JAMA Intern Med (2014) 1.58
Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study. BMJ (2013) 1.58
Improving care of patients at-risk for osteoporosis: a randomized controlled trial. J Gen Intern Med (2007) 1.56
Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance. J Clin Epidemiol (2009) 1.56
Costs and benefits of free medications after myocardial infarction. Healthc Policy (2009) 1.54
Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use. J Gen Intern Med (2007) 1.50
Nonexperimental comparative effectiveness research using linked healthcare databases. Epidemiology (2011) 1.50
Adherence to statin therapy in elderly patients after hospitalization for coronary revascularization. Am J Cardiol (2011) 1.49
Discontinuation and reinitiation patterns of osteoporosis treatment among commercially insured postmenopausal women. Int J Gen Med (2013) 1.49
Effect of electronic prescribing with formulary decision support on medication use and cost. Arch Intern Med (2008) 1.47
Design of cluster-randomized trials of quality improvement interventions aimed at medical care providers. Med Care (2007) 1.47
Gender and racial disparities in adherence to statin therapy: a meta-analysis. Am Heart J (2013) 1.46
The role of the c-statistic in variable selection for propensity score models. Pharmacoepidemiol Drug Saf (2010) 1.45
Effect of the Women's Health Initiative on osteoporosis therapy and expenditure in Medicaid. J Bone Miner Res (2006) 1.43
Adherence with osteoporosis practice guidelines: a multilevel analysis of patient, physician, and practice setting characteristics. Am J Med (2004) 1.42
Physician perceptions about generic drugs. Ann Pharmacother (2011) 1.40
Changing patterns of anemia management in US hemodialysis patients. Am J Med (2012) 1.39
Cost-effectiveness of genotype-guided warfarin dosing for patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes (2009) 1.38
Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence. Med Care (2013) 1.38
The impact of medication adherence on coronary artery disease costs and outcomes: a systematic review. Am J Med (2013) 1.36
A systematic review of adherence to cardiovascular medications in resource-limited settings. J Gen Intern Med (2011) 1.33
Healthcare information technology interventions to improve cardiovascular and diabetes medication adherence. Am J Manag Care (2010) 1.32
More on reports of esophageal cancer with oral bisphosphonate use. N Engl J Med (2009) 1.31
Prescription drug insurance coverage and patient health outcomes: a systematic review. Am J Public Health (2015) 1.27
Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes. CMAJ (2011) 1.26
Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes (2012) 1.26
Physicians' perceptions of relevant prescription drug costs: do costs to the individual patient or to the population matter most? Am J Manag Care (2006) 1.25
Disease transmission models for public health decision making: analysis of epidemic and endemic conditions caused by waterborne pathogens. Environ Health Perspect (2002) 1.24
Completeness of prescription information in US commercial claims databases. Pharmacoepidemiol Drug Saf (2013) 1.23
Impact of Medicaid prior authorization on angiotensin-receptor blockers: can policy promote rational prescribing? Health Aff (Millwood) (2007) 1.22